We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type



19 results found


Paul Hastings LLP | USA | 11 Apr 2019

Not a U.S.-Fits-All-Proposition: Four Key Considerations When Building the Compliance Framework to Go Global with Patient SupportPart I of II

Within the U.S., patient support programs (“PSPs”) have drawn increased regulator scrutiny, consistent with their growing importance in the healthcare


Paul Hastings LLP | Italy | 25 Jan 2019

The So-Called “Bribe Destroyer” Law on Corruption Adopted in Italy

With the publication of Law No. 3 of January 9, 2019 (“Law 919” or the “Law"), 1 Italy introduced some additional provisions aimed at fighting


Paul Hastings LLP | USA, United Kingdom, France | 16 Apr 2018

French Anticorruption Agency Issues Detailed New Guidelines for Compliance with Sapin II

The new French Anticorruption Agency (Agence Française Anticorruption, or AFA) recently issued a set of guidelines detailing the AFA’s expectations


Paul Hastings LLP | Brazil | 18 May 2017

Time to Clean Up: As Operation Car Wash Progresses, Are Medical Device and Pharmaceutical Companies Out of Time with the Brazilian Anti-Corruption Authorities?

For many business, compliance, and legal insiders within the life sciences sector, there has long been uneasiness around the relative ‘quiet’ from


Paul Hastings LLP | China | 19 May 2016

Recent Developments Strengthen Chinese Anti-Bribery Law

The Year of the Sheep was a banner year for anti-corruption enforcement in China. Government-led investigations reached an all-time high, with

Previous page 1 2